Efficacy and Renal Safety of Prophylactic Tenofovir Alafenamide for HBV-Infected Cancer Patients Undergoing Chemotherapy

Efficacy and Renal Safety of Prophylactic Tenofovir Alafenamide for HBV-Infected Cancer Patients Undergoing Chemotherapy

There are no data comparing the efficacy and safety of prophylactic entecavir (ETV), tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF) for HBV-infected cancer patients undergoing chemotherapy. This study aimed to compare the efficacy and renal safety of ETV, TDF and TAF in this set...

Full description

Bibliographic Details
Main Authors: I-Cheng Lee, Keng-Hsin Lan, Chien-Wei Su, Chung-Pin Li, Yee Chao, Han-Chieh Lin, Ming-Chih Hou, Yi-Hsiang Huang
Format: Article
Language:English
Published: MDPI AG 2022-09-01
Series:International Journal of Molecular Sciences
Subjects:
hepatitis B virus
cancer
chemotherapy
entecavir
tenofovir disoproxil fumarate
tenofovir alafenamide
Online Access:https://www.mdpi.com/1422-0067/23/19/11335

Internet

https://www.mdpi.com/1422-0067/23/19/11335

Similar Items